EPLive 2026: An International Symposium on Complex Cardiac Arrhythmias
On May 28 and 29, 2026, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its eighth international symposium, known as EPLive 2026. This renowned event, held biennially since 2012, is dedicated to advancing education in the field of cardiac electrophysiology. It welcomes healthcare professionals—from physicians to nurses—who focus on the complexities of heart rhythm disorders. At the core of this symposium are live cases featuring commentary from leading experts broadcast from TCAI’s cutting-edge electrophysiology center.
Dr. Andrea Natale, recognized as a prominent heart electrophysiologist and the medical director of TCAI, expressed the unique value of EPLive 2026, stating, "This is a rare opportunity for the global electrophysiology community to engage in real-time, case-based learning." The symposium integrates live procedures demonstrating the latest advances with expert discussions aimed at optimizing clinical practices and improving patient outcomes.
One of the highlights of EPLive 2026 is its innovative approach to treating arrhythmias. This year, the symposium will showcase a combined procedure that targets atrial fibrillation (AF) and the closure of the left atrial appendage (LAA) in one session. By addressing the arrhythmia and its common stroke risk concurrently, physicians can reduce patient intervention times and complications, promoting safer and more efficient care.
The conference will be divided into four sessions. These include AF ablation cases, ventricular tachycardia (VT) ablation cases, LAA closure procedures, and discussions about new devices and technologies. Collaborators from around the globe are involved, featuring contributions from leading electrophysiology centers in Belgium, Canada, Colombia, Italy, and various prestigious institutions within the United States.
Furthermore, EPLive aims to pinpoint strategies to decrease complications and enhance patient safety during AF ablation and other cardiac procedures. It will provide insights on adapting new technologies to improve clinical outcomes, ensuring participants are well-equipped with the knowledge needed in their practice today.
The event also allows multiple TCAI physicians, including course co-directors Dr. Amin Al-Ahmad, Dr. Luigi DiBiase, and Dr. Dhanunjaya "DJ" Lakkireddy, to contribute their expertise. Attendees can earn up to 14.5 American Medical Association (AMA) Physician's Recognition Award (PRA) Category 1 Credit™ hours, making it a highly beneficial event for medical professionals seeking to expand their qualifications and enhance their knowledge.
The Texas Cardiac Arrhythmia Institute is proud of its role as a leading center for robotic electrophysiology in North America, operating in a state-of-the-art facility that spans 72,000 square feet and is equipped with six electrophysiology labs featuring advanced technologies to treat complex heart rhythm disorders. With a team of globally recognized physicians, TCAI offers unmatched experience and care to its patients.
For more information regarding the symposium, visit EP-Live.com. This event not only marks a significant gathering for healthcare professionals but also reflects TCAI's ongoing commitment to advancing cardiac care through innovation and education.
EPLive 2026 represents an exceptional platform for learning and collaboration among some of the best minds in cardiac electrophysiology. By participating, healthcare professionals gain not just knowledge, but also actionable insights to apply in their practices, ultimately improving patient outcomes in the realm of complex arrhythmias.
Dr. Andrea Natale, recognized as a prominent heart electrophysiologist and the medical director of TCAI, expressed the unique value of EPLive 2026, stating, "This is a rare opportunity for the global electrophysiology community to engage in real-time, case-based learning." The symposium integrates live procedures demonstrating the latest advances with expert discussions aimed at optimizing clinical practices and improving patient outcomes.
One of the highlights of EPLive 2026 is its innovative approach to treating arrhythmias. This year, the symposium will showcase a combined procedure that targets atrial fibrillation (AF) and the closure of the left atrial appendage (LAA) in one session. By addressing the arrhythmia and its common stroke risk concurrently, physicians can reduce patient intervention times and complications, promoting safer and more efficient care.
The conference will be divided into four sessions. These include AF ablation cases, ventricular tachycardia (VT) ablation cases, LAA closure procedures, and discussions about new devices and technologies. Collaborators from around the globe are involved, featuring contributions from leading electrophysiology centers in Belgium, Canada, Colombia, Italy, and various prestigious institutions within the United States.
Furthermore, EPLive aims to pinpoint strategies to decrease complications and enhance patient safety during AF ablation and other cardiac procedures. It will provide insights on adapting new technologies to improve clinical outcomes, ensuring participants are well-equipped with the knowledge needed in their practice today.
The event also allows multiple TCAI physicians, including course co-directors Dr. Amin Al-Ahmad, Dr. Luigi DiBiase, and Dr. Dhanunjaya "DJ" Lakkireddy, to contribute their expertise. Attendees can earn up to 14.5 American Medical Association (AMA) Physician's Recognition Award (PRA) Category 1 Credit™ hours, making it a highly beneficial event for medical professionals seeking to expand their qualifications and enhance their knowledge.
The Texas Cardiac Arrhythmia Institute is proud of its role as a leading center for robotic electrophysiology in North America, operating in a state-of-the-art facility that spans 72,000 square feet and is equipped with six electrophysiology labs featuring advanced technologies to treat complex heart rhythm disorders. With a team of globally recognized physicians, TCAI offers unmatched experience and care to its patients.
For more information regarding the symposium, visit EP-Live.com. This event not only marks a significant gathering for healthcare professionals but also reflects TCAI's ongoing commitment to advancing cardiac care through innovation and education.
Conclusion
EPLive 2026 represents an exceptional platform for learning and collaboration among some of the best minds in cardiac electrophysiology. By participating, healthcare professionals gain not just knowledge, but also actionable insights to apply in their practices, ultimately improving patient outcomes in the realm of complex arrhythmias.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.